UPDATE 2-Novo bullish on 2015 goals, untroubled by U.S. competition

COPENHAGEN, Jan 30 (Reuters) - Danish insulin maker Novo Nordisk said it not expect significant pressure this year on its business in the United States, where rivals are fighting for its market share, after reporting on Friday a stronger fourth quarter than expected.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.